GILEAD SCIENCES INC

10% owner at Arcellx, Inc. · on record since Dec 28, 2023
10% owner at Kyverna Therapeutics, Inc. · on record since Feb 13, 2024
10% owner at ACHILLION PHARMACEUTICALS INC · on record since Oct 25, 2006
10% owner at CYPHERPUNK TECHNOLOGIES INC. · on record since Apr 19, 2024
10% owner at Xilio Therapeutics, Inc. · on record since Apr 3, 2024
10% owner at ASSEMBLY BIOSCIENCES, INC. · on record since May 27, 2026
10% owner at Arcus Biosciences, Inc. · on record since Jul 17, 2020
10% owner at Jounce Therapeutics, Inc. · on record since Oct 26, 2020
10% owner at CRAFT BREW ALLIANCE, INC. · on record since Feb 17, 2022
10% owner at Kalaris Therapeutics, Inc. · on record since Aug 5, 2022

Insider trading activity of GILEAD SCIENCES INC

Transactions on record: 30; since Nov 2, 2006

Open-market buys: 11; $628.1M

Open-market sells: 0

Companies traded: 6; last filing May 27, 2026

Figures computed from official regulatory filings — .

Companies where GILEAD SCIENCES INC has traded

ASSEMBLY BIOSCIENCES, INC.7 tx · $32.6M · May 27, 2026
Xilio Therapeutics, Inc.11 tx · $23.5M · Feb 17, 2026
Arcus Biosciences, Inc.4 tx · $574.8M · Feb 20, 2025
Kyverna Therapeutics, Inc.4 tx · $20M · Feb 13, 2024
Kalaris Therapeutics, Inc.1 tx · $11M · Jun 28, 2023
3 tx · Nov 2, 2006

Track record of GILEAD SCIENCES INC

Statistical track record

Free account

Open-market buys: 21

Last buy: Feb 13, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of GILEAD SCIENCES INC

Co-insiders of GILEAD SCIENCES INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ASSEMBLY BIOSCIENCES, INC.Listing on record	May 27, 2026	Award	471,698	26.50 USD	$12.5M		SEC
Xilio Therapeutics, Inc.Listing on record	Feb 17, 2026	BuyD (derivative)	3,739,000	0.53 USD	$2M		SEC
Xilio Therapeutics, Inc.Listing on record	Dec 1, 2025	OtherD (derivative)	13,335,000	0.75 USD	$10M		SEC
Xilio Therapeutics, Inc.Listing on record	Dec 1, 2025	OtherD (derivative)	-13,335,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Oct 3, 2025	Buy	2,295,920	—	n/a (No price was disclosed in the filing)	conv 56	SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Oct 3, 2025	BuyD (derivative)	1,147,960	—	n/a (No price was disclosed in the filing)		SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Oct 3, 2025	BuyD (derivative)	1,147,960	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Arcus Biosciences, Inc.Listing on record	Feb 20, 2025	Buy	1,363,636	11.00 USD	$15M	conv 31	SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Dec 23, 2024	Buy	940,499	21.37 USD	$20.1M	conv 40	SEC
Xilio Therapeutics, Inc.Listing on record	Dec 19, 2024	BuyD (derivative)	6,092,816	1.04 USD	$6.3M		SEC
Xilio Therapeutics, Inc.Listing on record	Dec 19, 2024	Buy	1,759,978	1.04 USD	$1.8M	conv 30	SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Jun 20, 2024	BuyD (derivative)	179,500	—	n/a (No price was disclosed in the filing)		SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Jun 20, 2024	Buy	179,500	—	n/a (No price was disclosed in the filing)	conv 32	SEC
Xilio Therapeutics, Inc.Listing on record	Apr 3, 2024	BuyD (derivative)	3,882,450	0.76 USD	$3M		SEC
Xilio Therapeutics, Inc.Listing on record	Apr 3, 2024	Buy	485,250	0.76 USD	$368.8K	conv 21	SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	Buy	910,000	22.00 USD	$20M	conv 41Cluster	SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	OtherD (derivative)	-7,746,139	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	OtherD (derivative)	-6,890,744	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	Other	3,216,119	—	n/a (No price was disclosed in the filing)		SEC
Arcus Biosciences, Inc.Listing on record	Jan 31, 2024	Buy	15,238,095	21.00 USD	$320M	conv 70	SEC
Arcus Biosciences, Inc.Listing on record	Jun 30, 2023	Buy	1,010,000	19.26 USD	$19.5M	conv 25	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ASSEMBLY BIOSCIENCES, INC.Listing on record	May 27, 2026	Award	471,698	26.50 USD	$12.5M		SEC
Xilio Therapeutics, Inc.Listing on record	Feb 17, 2026	BuyD (derivative)	3,739,000	0.53 USD	$2M		SEC
Xilio Therapeutics, Inc.Listing on record	Dec 1, 2025	OtherD (derivative)	13,335,000	0.75 USD	$10M		SEC
Xilio Therapeutics, Inc.Listing on record	Dec 1, 2025	OtherD (derivative)	-13,335,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Oct 3, 2025	Buy	2,295,920	—	n/a (No price was disclosed in the filing)	conv 56	SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Oct 3, 2025	BuyD (derivative)	1,147,960	—	n/a (No price was disclosed in the filing)		SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Oct 3, 2025	BuyD (derivative)	1,147,960	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Jun 6, 2025	BuyD (derivative)	13,335,000	—	n/a (No price was disclosed in the filing)		SEC
Arcus Biosciences, Inc.Listing on record	Feb 20, 2025	Buy	1,363,636	11.00 USD	$15M	conv 31	SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Dec 23, 2024	Buy	940,499	21.37 USD	$20.1M	conv 40	SEC
Xilio Therapeutics, Inc.Listing on record	Dec 19, 2024	BuyD (derivative)	6,092,816	1.04 USD	$6.3M		SEC
Xilio Therapeutics, Inc.Listing on record	Dec 19, 2024	Buy	1,759,978	1.04 USD	$1.8M	conv 30	SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Jun 20, 2024	BuyD (derivative)	179,500	—	n/a (No price was disclosed in the filing)		SEC
ASSEMBLY BIOSCIENCES, INC.Listing on record	Jun 20, 2024	Buy	179,500	—	n/a (No price was disclosed in the filing)	conv 32	SEC
Xilio Therapeutics, Inc.Listing on record	Apr 3, 2024	BuyD (derivative)	3,882,450	0.76 USD	$3M		SEC
Xilio Therapeutics, Inc.Listing on record	Apr 3, 2024	Buy	485,250	0.76 USD	$368.8K	conv 21	SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	Buy	910,000	22.00 USD	$20M	conv 41Cluster	SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	OtherD (derivative)	-7,746,139	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	OtherD (derivative)	-6,890,744	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kyverna Therapeutics, Inc.Listing on record	Feb 13, 2024	Other	3,216,119	—	n/a (No price was disclosed in the filing)		SEC
Arcus Biosciences, Inc.Listing on record	Jan 31, 2024	Buy	15,238,095	21.00 USD	$320M	conv 70	SEC
Arcus Biosciences, Inc.Listing on record	Jun 30, 2023	Buy	1,010,000	19.26 USD	$19.5M	conv 25	SEC